P
Porton Pharma Solutions Ltd
SZSE:300363
Porton Pharma Solutions Ltd
SZSE:300363
Price:
15.3 CNY
-1.23%
Market Closed
Updated:
May 25, 2024
Porton Pharma Solutions Ltd
Research & Development
|
Porton Pharma Solutions Ltd
Research & Development Peer Comparison
Comparables:
H
3692
600436
600276
000538
S
688506
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
P
|
Porton Pharma Solutions Ltd
SZSE:300363
|
Research & Development
-¥370.7m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Research & Development
-¥2.1B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Research & Development
-¥228.3m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Research & Development
-¥5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Research & Development
-¥329.2m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Research & Development
-¥712.5m
|
CAGR 3-Years
-61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Porton Pharma Solutions Ltd's Research & Development?
Research & Development
-370.7m
CNY
-370.7m
CNY
Based on the financial report for Mar 31, 2024, Porton Pharma Solutions Ltd's Research & Development amounts to -370.7m CNY.
What is Porton Pharma Solutions Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-44%
-44%
Over the last year, the Research & Development growth was 36%. The average annual Research & Development growth rates for Porton Pharma Solutions Ltd have been -25% over the past three years , -44% over the past five years .
You don't have any saved screeners yet
